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A B S T R A C T
Observational studies suggest childhood externalizing disorders are associated with increased smoking and
earlier initiation. However, causality cannot be inferred from observational data alone. The current study uses
two-sample MR to examine the causal relationship between externalizing behaviors and tobacco use.
Single nucleotide polymorphisms (SNPs) associated with aggression were obtained from the Early Life
Epidemiology Consortium (mean age 8), ADHD from the Integrative Psychiatric Research and Psychiatric
Genomics Consortiums (age range 6–18), and tobacco initiation and age of onset from the Tobacco and Genetics
Consortium. SNPs were combined using the inverse variance weighted approach, weighted median approach,
and MR-Egger regression.
There was no clear evidence of an eﬀect of aggression on tobacco initiation or age of onset for childhood
aggression (initiation: β −0.002, 95% CI −0.005, 0.001, P= 0.286; age: β −0.001 95% CI −0.002, 0.000,
P=0.310) or adolescent aggression (initiation: β−0.001, 95% CI−0.006, 0.003, P= 0.610; age: β 0.000, 95%
CI 0.000, 0.001, P= 0.183)]. However, there was some evidence of an association of ADHD on tobacco in-
itiation (OR 1.23, 95% CI 1.10, 1.35, P= 0.016), although no clear evidence of an eﬀect of ADHD on age of
onset (OR=1.022, 95% CI 0.992, 1.052, P=0.215).
Our results provide some evidence that genetic risk of childhood ADHD is causally related to increased risk of
tobacco initiation; however, the causal estimate is relatively small. We found no clear evidence that genetic risk
of childhood aggression is causally related to the risk of tobacco initiation or age of onset.
1. Introduction
Externalizing disorders such as conduct disorder (CD) and attention-
deﬁcit hyperactivity disorder (ADHD) are characterized by behaviors
including aggressiveness, impulsivity, sensation seeking, and often
criminal behavior at older ages (Brazil et al., 2016; Goldstein et al.,
2017; Holmes et al., 2001). Externalizing disorders are strongly asso-
ciated with substance use, including tobacco use (Brook et al., 2014;
Kim et al., 2009; Brook et al., 2010), and externalizing behaviors or
symptoms below a clinical threshold are similarly associated with in-
creased risk of smoking (Kollins et al., 2005). Individuals with ex-
ternalizing disorders have similar rates of smoking as other psychiatric
disorders (∼>40%), experience higher rates of smoking, earlier onset
of smoking, and greater nicotine dependency (Pomerleau et al., 1995;
John et al., 2004; Lasser et al., 2000; Bagot et al., 2007).
Externalizing disorders are associated with deﬁcits in reward
function – reduced sensitivity to favorable stimuli and increased reward
sensitivity. (Verdejo-Garcia et al., 2008). For example, ADHD is char-
acterized by abnormal functioning of the striatal dopaminergic system
and disruptions in dopaminergic transmission within corticostriatal
circuits, resulting in executive functioning deﬁcits (McClernon and
Kollins, 2008; Solanto, 1998). These individuals display decreased do-
pamine (DA) tone from below-normal presynaptic activation of DA
autoreceptors resulting in exaggerated DA release to salient stimuli
(McClernon and Kollins, 2008). In both clinical and preclinical studies,
nicotine is shown to stimulate striatal DA release, suggesting nicotine-
stimulated DA release may be more rewarding in individuals with
ADHD (McClernon and Kollins, 2008; Corrigall et al., 1994; Brody
et al., 2004). Therefore, individuals with ADHD may ﬁnd higher levels
of reward reinforcement from initial tobacco use, which may, in turn,
facilitate the transition to continued use (McClernon and Kollins, 2008).
Additionally, externalizing disorders are characterized by impulsive
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behavior (behavior that lacks foresight, evaluation, and inhibitory
control). These individuals typically prefer immediate rewards (over
possible larger rewards in the future) (Verdejo-Garcia et al., 2008).
Therefore, impulsivity may lead individuals to choose rewarding sti-
muli despite the possibility of negative outcomes. A hypersensitive re-
ward system may predispose individuals to early-onset substance use or
mediate the transition from experimental to more frequent/ daily use
(Aklin et al., 2009). Animal studies have supported this hypothesis, as
rodents divided into ‘high-impulsivity’ and ‘low impulsivity’ groups
based on attentional tasks show diﬀerential response to drug self-ad-
ministration. High-impulsive displayed more rapid acquisition and
higher rates of drug self-administration in response to decreased levels
of dopamine D2-receptor binding (Dalley et al., 2007). These ﬁndings
are mirrored in human PET studies where decreased striatum D2-re-
ceptor density is observed in addicted individuals, resulting in in-
creased positive psychological and physiological response to initial
drug exposure (Volkow et al., 1993, 1996; Wang et al., 1996).
Tobacco may also be used for self-medication in individuals with
ADHD to alleviate ADHD symptoms through negative reinforcement
(Laucht et al., 2007; Rodriguez et al., 2008). Studies using transdermal
nicotine patches alongside stimulant medicine have displayed increased
attention capabilities in adult ADHD patients (Gehricke et al., 2006).
Furthermore, studies using nicotine patches in non-smoking ADHD
patients have displayed increases in attention and cognition similar to
methylphenidate (Potter and Newhouse, 2004), improved behavioral
inhabitation (Potter and Newhouse, 2004) and increased positive aﬀect
(Levin et al., 1996; Rodriguez et al., 2008; McClernon and Kollins,
2008).
However, the causal nature of this relationship and the direction of
causality remain unclear. Evidence from longitudinal studies suggests
that externalizing behaviors in children are associated with subsequent
early onset tobacco use (Korhonen et al., 2010; Brook et al., 2010;
Crone and Reijneveld, 2007; Audrain-McGovern et al., 2004), and while
reverse causality is unlikely in this context due to the onset of ex-
ternalizing disorders in young children (prior to average smoking in-
itiation∼age 15), residual confounding may still be operating (e.g. via
intrauterine tobacco exposure). Experimental studies are typically im-
possible in substance use research for long-term outcomes for obvious
ethical and practical reasons. While we can examine the association
between externalizing behaviors and tobacco use in observational stu-
dies, these have provided conﬂicting evidence on the temporal direc-
tion of association (Korhonen et al., 2010; Cadoret et al., 1983; Brook
et al., 2010; Crone and Reijneveld, 2007; Hicks et al., 2009). Ulti-
mately, however, conventional epidemiological methods using ob-
servational data cannot support a strong causal inference as problems
such as selection bias, reverse causation, and residual confounding is
inherent in observational data (Davey Smith and Ebrahim, 2001). It is
therefore important to consider alternative methods to support the
stronger causal inference, such as the use of negative controls, cross-
contextual designs, and instrumental variable analysis (Gage et al.,
2016b). One type of instrumental variable analysis is Mendelian ran-
domization (MR), in which genetic variants robustly are predicting an
exposure of interest is used as an unconfounded proxy for that ex-
posure. Therefore, any associations found between these genetic var-
iants and the outcome provide evidence of a casual eﬀect of the ex-
posure captured by the genetic variants on the outcome, without the
risk of reverse causation or confounding. Two-sample MR uses variant-
exposure associations identiﬁed via genome-wide association studies
(GWAS), and variant-outcome associations from another independent
GWAS, using publicly-available summary data (Burgess et al., 2015).
The current study uses two-sample MR to examine the causal re-
lationship between externalizing behaviors and tobacco initiation
(Bowden et al., 2015).To compare across the spectrum of externalizing
disorders we used data available from both an aggression and an ADHD
GWAS.
2. Methods
2.1. Exposure measures
For our externalizing behaviors exposure, we used summary data
from the Early Life Epidemiology Consortium (EAGLE) consortium
GWAS of aggressive behavior on a sample of 18,988 individuals.
Aggression was measured using continuous study-speciﬁc scales (Pappa
et al., 2016). Six SNPs were identiﬁed as the top SNPs approaching
genome-wide signiﬁcance (P < 5×10−5) for aggression. The GWAS
further identiﬁed top SNPs stratiﬁed by age group, with ﬁve SNPs ap-
proaching genome-wide signiﬁcance for early childhood (mean age
5.36 years, SD 1.5), and six SNPs for middle childhood/early adoles-
cence (mean age 11.39 years, SD 1.86) (see Supplementary Table S1).
For our ADHD exposure, we used summary data from the Initiative
for Integrative Psychiatric Research (iPSYCH) and Psychiatric Genomics
Consortium (PGC) GWAS of ADHD on 55,354 individuals (ages 6–19)
(Demontis et al., 2017). ADHD was measured using the binary cohort-
speciﬁc diagnosis of ADHD. Fourteen independent SNPs (were identi-
ﬁed as genome-wide signiﬁcant (P < 5×10−8) (see Supplementary
Table S2).
2.2. Outcome measures
For our tobacco initiation outcome, we used summary data from the
Tobacco and Genetics Consortium (TAG) GWAS of smoking behavior
(Tobacco and Genetics Consortium, 2010). Tobacco initiation
(n= 74,053) was a binary ever/never measure and age of initiation
(n= 24,114) was the reported age at which participants started
smoking.
2.3. Statistical analyses
SNPs associated with aggression and ADHD were identiﬁed in their
respective GWAS and subsequently extracted from the tobacco GWAS
(see Supplementary Tables S1–S2). Where original SNPs were un-
available, proxy SNPs were identiﬁed using SNiPA (http://snipa.
helmholtz-muenchen.de/snipa3/) with an r2 threshold of ≥0.9. SNP-
exposure and SNP-outcome associations were combined using an in-
verse-variance weighted approach (IVW), weighted median approach,
and MR-Egger regression. Here, we use multiple methods, each with
diﬀering underlying assumptions regarding instrument validity, to tri-
angulate our results (Lawlor et al., 2016). IVW weights regression of
SNP-exposure and SNP-outcome coeﬃcients restricting the intercept to
zero, and assumes all instruments are valid with no pleiotropy (Burgess
et al., 2013). Weighed median provides a causal estimate if at least 50%
of the instruments are valid (Mostafavi et al., 2016). MR-Egger uses an
intercept coeﬃcient in the weighted regression to relax the assumption
that the outcome works strictly via the exposure (i.e., up to 100% of the
instruments may be invalid). The intercept term displays the overall
pleiotropic eﬀect, while the slope (β) coeﬃcient displays a causal es-
timate under the assumption the pleiotropic eﬀects of the SNP on the
outcome are unrelated to the associations between the SNP and ex-
posure (Corbin et al., 2016). Finally, I2 statistics were calculated to
determine heterogeneity between estimates from multiple genetic in-
struments, with higher numbers indicating greater heterogeneity which
could indicate potential violations of the MR assumptions. Main ﬁnd-
ings are presented as IVW within the text. To avoid inference based
simply on P-value thresholds, the direction and strength of eﬀect for
each association, together with the corresponding P-value, is presented
(Sterne and Davey Smith, 2001). All analyses were conducted in R
(version 3.3.2). Additionally, there was no direct overlap between
samples. However, it is possible some parents in the TAG may have
oﬀspring included in EAGLE.
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3. Results
3.1. Aggression and tobacco initiation
There was no clear evidence of an eﬀect from the genetic risk of
aggression to tobacco use initiation (βIVW<0.001, 95% CI −0.003 to
0.002, P=0.810). While the MR-Egger analysis suggested there is
some evidence of an eﬀect on initiation, the eﬀect estimates were in-
consistent with those from the IVW and weighted median analyses (see
Table 1 for full results). Findings were similar when looking at the eﬀect
from the genetic risk of aggression to age at onset, with no clear evi-
dence of an eﬀect observed (βIVW< 0.001, 95% CI: 0.000–0.001,
P=0.125). These ﬁndings were consistent when restricted to early
childhood and late adolescence (see Table 1). There was moderate to
high heterogeneity (see Table 1 for full results).
3.2. ADHD and tobacco initiation
There was weak evidence of an association from the genetic risk of
ADHD to tobacco initiation (ORIVW 1.23, 95% CI 1.10–1.35,
P=0.016), and low heterogeneity (I2 = 29%). Although MR-Egger
analysis indicated that there was some evidence of pleiotropy
(ORIntercept 1.06, 95% CI 1.03–1.09, P=0.020), the bias-adjusted eﬀect
estimate remained consistent with that estimated using the IVW ap-
proach and suggested some weak evidence of a causal eﬀect (ORSlope
1.40, 95% CI 1.10–1.78, P= 0.087). There was no clear evidence of an
eﬀect from the genetic risk of ADHD to the age of onset (see Table 2 for
full results).
3.3. Power calculation
Post-hoc power calculations were conducted for our IVW analyses
using an online Mendelian randomization power calculation tool
(https://sb452.shinyapps.io/power/) (Burgess, 2014). For the analysis
investigating the eﬀect of aggression with tobacco use initiation, using
a genetic instrument that explains 1% of the variation in aggression and
a sample containing 28% smoking cases, our study has 77% power to
detect a causal eﬀect of β=0.1. Power was similar when looking at the
eﬀect of aggression on age at onset. For the analysis investigating the
eﬀect of ADHD with tobacco use initiation, using a genetic instrument
which explains 2% of the variation in ADHD and a sample containing
28% smoking cases, our study has 73% power to detect a causal eﬀect
of OR=1.2. Power was similar when looking at the eﬀect of ADHD on
age at onset.
4. Discussion
Our results provide some evidence that genetic risk of childhood
ADHD is causally related to increased risk of tobacco initiation; how-
ever, the causal estimate is relatively small. We found no clear evidence
that genetic risk of childhood aggression is causally related to the risk of
tobacco initiation or age of onset. Therefore, the observational evidence
relating to these associations (Kretschmer et al., 2014; Disney et al.,
1999; Korhonen et al., 2010; Rohde et al., 2004) may not be causal and
may be due to environmental or confounding factors.
Our ﬁndings with respect to genetic risk of ADHD and tobacco use
initiation correspond with observational evidence (Breyer et al., 2014;
Milberger et al., 1997; Kollins et al., 2005; Lambert and Hartsough,
1998), and the converging evidence from diﬀerent MR methodologies
provides further conﬁdence in these ﬁndings. Neurobiological evidence
also supports these causal associations (McClernon et al., 2008).
However, as the MR-Egger analyses suggest some evidence of hor-
izontal pleiotropy, the use of alternative causal inference methods re-
lying on diﬀerent assumptions (e.g. cross-contextual comparisons
across populations where confounding structures diﬀer) will allow tri-
angulation to determine whether these results do reﬂect true causal
Table 1
Estimates of the causal eﬀects of the risk of aggression behaviors on tobacco initiation and age of onset using IVW, MR-Egger and weighted median Mendelian
randomization approaches.
Initiation Age of onset
Method β 95% CI P value β 95% CI P value
Aggression (all ages, mean age=8.4)
IVW 0.000 −0.003, 0.002 0.810 0.000 0.000, 0.001 0.125
Weighted median 0.001 −0.003, 0.002 0.759 0.000 0.000, 0.001 0.161
MR-Egger slope −0.039 −0.056, −0.021 0.012 0.004 −0.001, 0.008 0.160
MR-Egger intercept 0.019 0.170, 0.204 0.012 −0.017 −0.038, 0.004 0.188
Heterogeneity I2= 36%
Aggression (early childhood, ages 3-7)
IVW −0.002 −0.005, 0.001 0.286 −0.001 −0.002, 0.000 0.310
Weighted median −0.003 −0.008, 0.003 0.388 0.000 −0.001, 0.001 0.578
MR-Egger slope −0.014 −0.024, 0.004 0.066 −0.001 −0.006, 0.004 0.812
MR-Egger intercept 0.032 0.007, 0.058 0.088 0.000 −0.013, 0.014 0.966
Heterogeneity I2= 82%
Aggression (late adolescent, ages 8-15)
IVW −0.001 −0.006, 0.003 0.610 0.000 0.000, 0.001 0.183
Weighted median −0.001 −0.006, 0.003 0.572 0.000 0.000, 0.001 0.292
MR-Egger slope −0.016 −0.005, 0.025 0.051 0.000 −0.002, 0.002 0.862
MR-Egger intercept −0.069 −0.113, −0.025 0.037 0.001 −0.008, 0.009 0.878
Heterogeneity I2= 93%
Table 2
Estimates of the causal eﬀects of the risk of ADHD on tobacco initiation and age
of onset using IVW, MR-Egger and weighted median Mendelian randomization
approaches.
Initiation Age of onset
Method OR 95% CI P value OR 95% CI P value
ADHD
IVW 1.230 1.110,
1.350
0.016 1.022 0.992,
1.052
0.215
Weighted
median
1.180 −1.033,
1.327
0.068 1.014 0.947,
1.081
0.705
MR-Egger slope 1.440 1.101,
1.779
0.087 0.928 0.797,
1.059
0.315
MR-Egger
intercept
1.060 −1.027,
1.093
0.020 1.004 0.997,
1.011
0.202
Heterogeneity I2= 29%
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relationships (Gage et al., 2015; Munafo and Davey Smith, 2018).
Within individuals with ADHD, a hypoactive striatal dopaminergic
system produces increased dopamine transporter within corticostriatal
circuits. This subsequently decreases dopamine tone and activation of
presynaptic autoreceptors, resulting in exaggerated dopamine response
to salient stimuli. As nicotine stimulates a response in the striatum of
smokers, nicotine-stimulated phasic dopamine releases may be more
rewarding for individuals with ADHD (Dresel et al., 2000; Krause et al.,
2002, 2003; Grace, 2001). Therefore, this heightened reward response
to dopamine in individuals with ADHD may be responsible for reward
and maintenance eﬀects (Krause et al., 2000; Grace, 2001).
These ﬁndings may help identify individuals particularly vulnerable
to tobacco use behaviors, and therefore provide interventions from an
early age. For example, previous evidence indicates that strong familial
bonds and open communication within families and schools may serve
as a protective factor, or help to delay adolescent substance initiation
(McArdle et al., 2002; Kliewer and Murrelle, 2007; Farrell and White,
1998; Spoth et al., 2004).
There are a number of important strengths to this study. The use of
Mendelian randomization analysis strengthens causal inference and
removes the possibility of reverse causation, confounding, and bias
(Gage et al., 2015, 2016a). Furthermore, we integrated multiple
methods with varying assumptions and strengths to formulate more
robust causal inferences (Gage et al., 2015). The use of two-sample MR
utilizes large sample sizes to provide the suﬃcient power required to
detect small eﬀects in complex phenotypes. However, there are also
some limitations to consider. Unlike childhood aggression, which was a
measurable trait of externalizing disorders, ADHD was only measured
as a binary diagnosis. Previous evidence has suggested that particular
traits of ADHD (i.e., inattention or impulsivity/hyperactivity) are more
associated with the increased likelihood of tobacco initiation
(McClernon et al., 2008). However, the current GWAS only examined
ADHD diagnosis and not by individual symptomology. A GWAS of these
individual traits has been conducted in adulthood (Mick et al., 2014),
but sample sizes were small, and summary statistics were unavailable.
Finally, we conducted several analyses, which raises the possibility that
some of the eﬀects we report may represent false positives. This should
be considered when interpreting our results as a whole.
Overall our results provided some evidence that there may be a
causal association of genetic risk of ADHD on tobacco initiation, these
results are in line with previous longitudinal and neurobiological evi-
dence. However, there was no association between early aggressive
behavior on tobacco initiation, suggesting these observed associations
may be a result of additional variables. Our results suggest that pre-
vention eﬀorts should target these risk groups, and explore whether
interventions to reduce these behaviors inﬂuence subsequent tobacco
use initiation. By identifying at-risk individuals, prevention behaviors
such as strengthening familial bonds, open communication within fa-
milies and schools, and early intervention education may help delay or
prevent adolescent substance use initiation. (Steinberg et al., 1994;
McArdle et al., 2002; Dishion et al., 2002; Kliewer and Murrelle, 2007;
Farrell and White, 1998; Spoth et al., 2004).
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